evaluation of vigabatrin as monotherapy in newly diagnosed partial seizures in childhood.

dc.contributor.authorPerniola, T.
dc.contributor.authorSpina, A.
dc.contributor.authorMargari, L.
dc.contributor.authorLosito, R.
dc.contributor.authorMarzocco, P.L.
dc.contributor.authorBello, A.
dc.contributor.authorZizzo, L.
dc.date.accessioned2013-06-28T11:13:29Z
dc.date.accessioned2017-10-16T11:37:05Z
dc.date.available2013-06-28T11:13:29Z
dc.date.available2017-10-16T11:37:05Z
dc.date.issued1997
dc.description.abstractFifty-three childreen with newly diagnosed partial epilepsies received GVG monotherapy (mean 44/mg/kg/day). After a mean follow up time of 16,5 months, 26 childreen (49%) were seazures-free, 18 (33,9%) had a decrease in seizure frequency and 9 childreen (16,9%) had unchanged seizure frequency. Side effects were reported in 22 childreen (41,5%) and included weight gain, increased appetite and restlessness.en_US
dc.identifier.citationPerniola, T., Spina, A., Margari, L., Losito, R., Marzocco, P. L., Bello, A., . . . Zizzo, L. (1997). Open evaluation of vigabatrin as monotherapy in newly diagnosed partial seizures in childhood. [Monoterapia con vigabatrin nell'epilessia parziale di nuova diagnosi in eta evolutiva: Valutazione in aperto dell' efficacia e della tollerabilita] Bollettino - Lega Italiana Contro l'Epilessia, (99), 141-143.en_US
dc.identifier.urihttp://197.255.68.203/handle/123456789/4278
dc.language.isoenen_US
dc.titleevaluation of vigabatrin as monotherapy in newly diagnosed partial seizures in childhood.en_US
dc.typeArticleen_US

Files

License bundle

Now showing 1 - 2 of 2
Loading...
Thumbnail Image
Name:
license.txt
Size:
1.82 KB
Format:
Item-specific license agreed upon to submission
Description:
Loading...
Thumbnail Image
Name:
license.txt
Size:
0 B
Format:
Item-specific license agreed upon to submission
Description: